Skip to main content
Clinical Trials/IRCT20240729062577N1
IRCT20240729062577N1RecruitingPhase 3

Evaluation of the effect of lidocaine 2%-dexamethasone composition and compare it with lidocaine 2% injection on postoperative endodontic pain

Shahre-kord University of Medical Sciences0 sites108 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
108

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
12 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Healthy people with ASA I and ASA II
  • The tooth has no history of pulp therapy
  • The state of the pulp is irreversible pulpitis to necrosis
  • Periapical condition of the tooth as acute or chronic periodontitis
  • Not taking painkillers and anti-inflammatory drugs in the last 12 hours
  • Absence of acute or chronic periapical abscess and acute periodontal abscess
  • No need to take prophylactic antibiotics
  • Absence of pregnancy
  • Absence of mental disability
  • Literate to read and write
  • Absence of systemic disease prohibiting root canal treatment
  • Absence of infectious disease or sensitivity to dexamethasone
  • Absence of tooth apex opening

Exclusion Criteria

  • People with ASA III and ASA IV
  • A tooth that requires multiple treatment sessions
  • Age more than 60 and less than 12 years

Investigators

Sponsor
Shahre-kord University of Medical Sciences

Similar Trials